{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:53:35Z","timestamp":1790952815326,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["Project ID: DFF \u2013 2032-00012B"],"award-info":[{"award-number":["Project ID: DFF \u2013 2032-00012B"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01117-w","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:32:21Z","timestamp":1743762741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Post-exposure vaccine protection of CTH522\/CAF\u00ae01 against reinfection with Chlamydia trachomatis requires Th1\/Th17 but not Th2-immunity"],"prefix":"10.1038","volume":"10","author":[{"given":"Nina Dieu Nhien Tran","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Subratheepam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Guleed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Mazanti","family":"Melchiors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Weinreich","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"W\u00f8rzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"1117_CR1","unstructured":"WHO. Global Health Sector Strategy on Sexually Transmitted Infections 2016\u20132021 Towards Ending STIs (WHO, 2016)."},{"key":"1117_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/648734","volume":"201","author":"BE Batteiger","year":"2010","unstructured":"Batteiger, B. E. et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J. Infect. Dis. 201, 42\u201351 (2010).","journal-title":"J. Infect. Dis."},{"key":"1117_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/AOG.0b013e31825a6bc9","volume":"120","author":"HC Wiesenfeld","year":"2012","unstructured":"Wiesenfeld, H. C., Hillier, S. L., Meyn, L. A., Amortegui, A. J. & Sweet, R. L. Subclinical pelvic inflammatory disease and infertility. Obstet. Gynecol. 120, 37\u201343 (2012).","journal-title":"Obstet. Gynecol."},{"key":"1117_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0028-2243(94)90048-5","volume":"57","author":"PK Heinonen","year":"1994","unstructured":"Heinonen, P. K. & Miettinen, A. Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 57, 85\u201389 (1994).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"1117_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","volume":"19","author":"L Westrom","year":"1992","unstructured":"Westrom, L., Joesoef, R., Reynolds, G., Hagdu, A. & Thompson, S. E. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex. Transm. Dis. 19, 185\u2013192 (1992).","journal-title":"Sex. Transm. Dis."},{"key":"1117_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0157-x","volume":"5","author":"N Nguyen","year":"2020","unstructured":"Nguyen, N. et al. Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge. NPJ Vaccines 5, 7 (2020).","journal-title":"NPJ Vaccines"},{"key":"1117_CR7","doi-asserted-by":"publisher","unstructured":"Nguyen, N. et al. Th1\/Th17 T cell tissue-resident immunity increases protection, but is not required in a vaccine strategy against genital infection with Chlamydia trachomatis. Front. Immunol., https:\/\/doi.org\/10.3389\/fimmu.2021.790463 (2021).","DOI":"10.3389\/fimmu.2021.790463"},{"key":"1117_CR8","doi-asserted-by":"publisher","unstructured":"Pollock, K. M. et al. An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial. Lancet Infect. Dis., https:\/\/doi.org\/10.1016\/S1473-3099(24)00147-6 (2024).","DOI":"10.1016\/S1473-3099(24)00147-6"},{"key":"1117_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45526-2","volume":"15","author":"AW Olsen","year":"2024","unstructured":"Olsen, A. W. et al. Immune signature of Chlamydia vaccine CTH522\/CAF\u00ae01 translates from mouse-to-human and induces durable protection in mice. Nat. Commun. 15, 1665 (2024).","journal-title":"Nat. Commun."},{"key":"1117_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","volume":"19","author":"S Abraham","year":"2019","unstructured":"Abraham, S. et al. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 19, 1091\u20131100 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1117_CR11","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1128\/IAI.68.12.6979-6987.2000","volume":"68","author":"SG Morrison","year":"2000","unstructured":"Morrison, S. G., Su, H., Caldwell, H. D. & Morrison, R. P. Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect. Immun. 68, 6979\u20136987 (2000).","journal-title":"Infect. Immun."},{"key":"1117_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.mucimm.2024.06.012","volume":"17","author":"TB Poston","year":"2024","unstructured":"Poston, T. B. et al. Viral-vectored boosting of OmcB- or CPAF-specific T-cell responses fail to enhance protection from Chlamydia muridarum in infection-immune mice and elicits a non-protective CD8-dominant response in naive mice. Mucosal Immunol. 17, 1005\u20131018 (2024).","journal-title":"Mucosal Immunol."},{"key":"1117_CR13","doi-asserted-by":"publisher","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","volume":"348","author":"G Stary","year":"2015","unstructured":"Stary, G. et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348, aaa8205 (2015).","journal-title":"Science"},{"key":"1117_CR14","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.4049\/jimmunol.1103032","volume":"189","author":"DC Gondek","year":"2012","unstructured":"Gondek, D. C., Olive, A. J., Stary, G. & Starnbach, M. N. CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract. J. Immunol. 189, 2441\u20132449 (2012).","journal-title":"J. Immunol."},{"key":"1117_CR15","doi-asserted-by":"publisher","unstructured":"Pal, S., Tifrea, D. F., Zhong, G. & de la Maza, L. M. Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice. Infect Immun 86, https:\/\/doi.org\/10.1128\/iai.00722-17 (2018).","DOI":"10.1128\/iai.00722-17"},{"key":"1117_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah, P. A. et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med 13, 843\u2013850 (2007).","journal-title":"Nat. Med"},{"key":"1117_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","volume":"11","author":"P He","year":"2015","unstructured":"He, P., Zou, Y. & Hu, Z. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum. Vaccines Immunotherapeutics 11, 477\u2013488 (2015).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"1117_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1086\/522524","volume":"196","author":"AW Olsen","year":"2007","unstructured":"Olsen, A. W. et al. Identification of human T cell targets recognized during Chlamydia trachomatis genital infection. J. Infect. Dis. 196, 1546\u20131552 (2007).","journal-title":"J. Infect. Dis."},{"key":"1117_CR19","doi-asserted-by":"publisher","first-page":"e13331","DOI":"10.1111\/sji.13331","volume":"99","author":"CW Armitage","year":"2024","unstructured":"Armitage, C. W. et al. IgG exacerbates genital chlamydial pathology in females by enhancing pathogenic CD8(+) T cell responses. Scand. J. Immunol. 99, e13331 (2024).","journal-title":"Scand. J. Immunol."},{"key":"1117_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/icb.2015.74","volume":"94","author":"KR Vlcek","year":"2016","unstructured":"Vlcek, K. R. et al. The contribution of Chlamydia-specific CD8(+) T cells to upper genital tract pathology. Immunol. Cell Biol. 94, 208\u2013212 (2016).","journal-title":"Immunol. Cell Biol."},{"key":"1117_CR21","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1073\/pnas.1711356115","volume":"115","author":"RS Lijek","year":"2018","unstructured":"Lijek, R. S., Helble, J. D., Olive, A. J., Seiger, K. W. & Starnbach, M. N. Pathology after infection is driven by nonprotective immune cells that are distinct from protective populations. Proc. Natl Acad. Sci. USA 115, 2216\u20132221 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1117_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm.2285","volume":"17","author":"C Aagaard","year":"2011","unstructured":"Aagaard, C. et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17, 189\u2013194 (2011).","journal-title":"Nat. Med."},{"key":"1117_CR23","doi-asserted-by":"publisher","first-page":"e76664","DOI":"10.1371\/journal.pone.0076664","volume":"8","author":"DW Andrew","year":"2013","unstructured":"Andrew, D. W. et al. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS One 8, e76664 (2013).","journal-title":"PLoS One"},{"key":"1117_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep19570","volume":"6","author":"NP Knudsen","year":"2016","unstructured":"Knudsen, N. P. et al. Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens. Sci. Rep. 6, 19570 (2016).","journal-title":"Sci. Rep."},{"key":"1117_CR25","doi-asserted-by":"publisher","unstructured":"Darville, T. et al. Anti-chlamydia IgG and IgA are insufficient to prevent endometrial chlamydia infection in women, and increased anti-chlamydia IgG is associated with enhanced risk for incident infection. Am. J. Reprod. Immunol. 81, https:\/\/doi.org\/10.1111\/aji.13103 (2019).","DOI":"10.1111\/aji.13103"},{"key":"1117_CR26","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1086\/652397","volume":"201","author":"T Darville","year":"2010","unstructured":"Darville, T. & Hiltke, T. J. Pathogenesis of Genital Tract Disease Due to. J. Infect. Dis. 201, S114\u2013S125 (2010).","journal-title":"J. Infect. Dis."},{"key":"1117_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae519","author":"H Yu","year":"2024","unstructured":"Yu, H. et al. Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations with Chlamydia Outcomes. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiae519 (2024).","journal-title":"J. Infect. Dis."},{"key":"1117_CR28","doi-asserted-by":"crossref","unstructured":"Pollock, K. M. et al. An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, doubleblind trial. Lancet Infect. Dis. 24, 829\u2013844 (2024).","DOI":"10.1016\/S1473-3099(24)00147-6"},{"key":"1117_CR29","first-page":"221","volume":"382","author":"S Mkaddem","year":"2014","unstructured":"Mkaddem, S. et al. IgA, IgA Receptors, and Their Anti-inflammatory Properties. Curr. Top. Microbiol 382, 221\u2013235 (2014).","journal-title":"Curr. Top. Microbiol"},{"key":"1117_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16717-3","volume":"7","author":"JAF Silva","year":"2017","unstructured":"Silva, J. A. F. et al. The origin of prostate gland-secreted IgA and IgG. Sci. Rep. 7, 16488 (2017).","journal-title":"Sci. Rep."},{"key":"1117_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/sj.pcan.4500629","volume":"6","author":"C Kastner","year":"2003","unstructured":"Kastner, C. & Jakse, G. Measurement of immunoglobulins in seminal fluid with modified nephelometry-an alternative diagnostic tool for chronic prostatitis. Prostate Cancer Prostatic Dis. 6, 86\u201389 (2003).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1117_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0022-5347(17)50387-0","volume":"131","author":"JE Fowler Jr.","year":"1984","unstructured":"Fowler, J. E. Jr. & Mariano, M. Longitudinal studies of prostatic fluid immunoglobulin in men with bacterial prostatitis. J. Urol. 131, 363\u2013369 (1984).","journal-title":"J. Urol."},{"key":"1117_CR33","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1128\/iai.39.3.1491-1494.1983","volume":"39","author":"RC Brunham","year":"1983","unstructured":"Brunham, R. C., Kuo, C. C., Cles, L. & Holmes, K. K. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect. Immun. 39, 1491\u20131494 (1983).","journal-title":"Infect. Immun."},{"key":"1117_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0264-410X(97)00206-5","volume":"15","author":"S Pal","year":"1997","unstructured":"Pal, S., Theodor, I., Peterson, E. M. & de la Maza, L. M. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 15, 575\u2013582 (1997).","journal-title":"Vaccine"},{"key":"1117_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1600-0897.2008.00637.x","volume":"60","author":"KA Cunningham","year":"2008","unstructured":"Cunningham, K. A. et al. Poly-immunoglobulin receptor-mediated transport of IgA into the male genital tract is important for clearance of Chlamydia muridarum infection. Am. J. Reprod. Immunol. 60, 405\u2013414 (2008).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1117_CR36","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1016\/j.vaccine.2004.04.021","volume":"22","author":"DK Hickey","year":"2004","unstructured":"Hickey, D. K. et al. Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate. Vaccine 22, 4306\u20134315 (2004).","journal-title":"Vaccine"},{"key":"1117_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/ni.2567","volume":"14","author":"PJ Milpied","year":"2013","unstructured":"Milpied, P. J. & McHeyzer-Williams, M. G. High-affinity IgA needs TH17 cell functional plasticity. Nat. Immunol. 14, 313\u2013315 (2013).","journal-title":"Nat. Immunol."},{"key":"1117_CR38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","volume":"44","author":"P Kumar","year":"2016","unstructured":"Kumar, P. et al. Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. Immunity 44, 659\u2013671 (2016).","journal-title":"Immunity"},{"key":"1117_CR39","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.4049\/jimmunol.1200955","volume":"189","author":"AT Cao","year":"2012","unstructured":"Cao, A. T., Yao, S., Gong, B., Elson, C. O. & Cong, Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J. Immunol. 189, 4666\u20134673 (2012).","journal-title":"J. Immunol."},{"key":"1117_CR40","doi-asserted-by":"publisher","unstructured":"Helble, J. D. & Starnbach, M. N. T cell responses to Chlamydia. Pathogens Dis. 79, https:\/\/doi.org\/10.1093\/femspd\/ftab014 (2021).","DOI":"10.1093\/femspd\/ftab014"},{"key":"1117_CR41","doi-asserted-by":"publisher","unstructured":"Helble, J. D., Gonzalez, R. J., von Andrian, U. H. & Starnbach, M. N. Gamma Interferon Is Required for Chlamydia Clearance but Is Dispensable for T Cell Homing to the Genital Tract. mBio 11, https:\/\/doi.org\/10.1128\/mBio.00191-20 (2020).","DOI":"10.1128\/mBio.00191-20"},{"key":"1117_CR42","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.4049\/jimmunol.0900295","volume":"183","author":"DC Gondek","year":"2009","unstructured":"Gondek, D. C., Roan, N. R. & Starnbach, M. N. T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis. J. Immunol. 183, 1313\u20131319 (2009).","journal-title":"J. Immunol."},{"key":"1117_CR43","first-page":"9","volume":"10","author":"NR Roan","year":"2008","unstructured":"Roan, N. R. & Starnbach, M. N. Immune-mediated control of Chlamydia infection. Cell Microbiol. 10, 9\u201319 (2008).","journal-title":"Cell Microbiol."},{"key":"1117_CR44","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1128\/IAI.66.11.5457-5461.1998","volume":"66","author":"MF Lampe","year":"1998","unstructured":"Lampe, M. F., Wilson, C. B., Bevan, M. J. & Starnbach, M. N. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect. Immun. 66, 5457\u20135461 (1998).","journal-title":"Infect. Immun."},{"key":"1117_CR45","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/infdis\/jiv137","volume":"212","author":"AW Olsen","year":"2015","unstructured":"Olsen, A. W., Follmann, F., Erneholm, K., Rosenkrands, I. & Andersen, P. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein. J. Infect. Dis. 212, 978\u2013989 (2015).","journal-title":"J. Infect. Dis."},{"key":"1117_CR46","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/imm.12520","volume":"146","author":"S Pal","year":"2015","unstructured":"Pal, S., Tatarenkova, O. V. & de la Maza, L. M. A vaccine formulated with the major outer membrane protein can protect C3H\/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Immunology 146, 432\u2013443 (2015).","journal-title":"Immunology"},{"key":"1117_CR47","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1046\/j.1365-3083.1997.d01-167.x","volume":"46","author":"M Johansson","year":"1997","unstructured":"Johansson, M., Schon, K., Ward, M. & Lycke, N. Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans? Scand. J. Immunol. 46, 546\u2013552 (1997).","journal-title":"Scand. J. Immunol."},{"key":"1117_CR48","doi-asserted-by":"publisher","first-page":"e1011914","DOI":"10.1371\/journal.ppat.1011914","volume":"20","author":"JA Rixon","year":"2024","unstructured":"Rixon, J. A. et al. Elimination of Chlamydia muridarum from the female reproductive tract is IL-12p40 dependent, but independent of Th1 and Th2 cells. PLoS Pathog. 20, e1011914 (2024).","journal-title":"PLoS Pathog."},{"key":"1117_CR49","doi-asserted-by":"publisher","first-page":"e1010333","DOI":"10.1371\/journal.ppat.1010333","volume":"18","author":"JA Rixon","year":"2022","unstructured":"Rixon, J. A., Depew, C. E. & McSorley, S. J. Th1 cells are dispensable for primary clearance of Chlamydia from the female reproductive tract of mice. PLoS Pathog. 18, e1010333 (2022).","journal-title":"PLoS Pathog."},{"key":"1117_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ni.1993","volume":"12","author":"K Hirota","year":"2011","unstructured":"Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255\u2013U295 (2011).","journal-title":"Nat. Immunol."},{"key":"1117_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","volume":"24","author":"A Schnell","year":"2023","unstructured":"Schnell, A., Littman, D. R. & Kuchroo, V. K. T(H)17 cell heterogeneity and its role in tissue inflammation. Nat. Immunol. 24, 19\u201329 (2023).","journal-title":"Nat. Immunol."},{"key":"1117_CR52","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1086\/508203","volume":"194","author":"AW Olsen","year":"2006","unstructured":"Olsen, A. W. et al. Identification of CT521 as a frequent target of Th1 cells in patients with urogenital Chlamydia trachomatis infection. J. Infect. Dis. 194, 1258\u20131266 (2006).","journal-title":"J. Infect. Dis."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01117-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01117-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01117-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T20:33:06Z","timestamp":1743798786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01117-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1117"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01117-w","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.W.O. and F.F. are co-inventors of a patent (WO2014146663A1) relating to C.t. vaccines. All rights have been assigned to Statens Serum Institut, a Danish not-for-profit governmental institute. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}